HIPK2 directs cell type-specific regulation of STAT3 transcriptional activity in Th17 cell differentiation.
Ka Lung CheungAnbalagan JaganathanYuan HuFeihong XuAlannah LejeuneRajal SharmaCristina I CaescuJamel MeslamaniAdam VincekFan ZhangKyung LeeNilesh ZawareAmina Abdul QayumChunyan RenMark H KaplanJohn Cijiang HeHuabao XiongMing-Ming ZhouPublished in: Proceedings of the National Academy of Sciences of the United States of America (2022)
SignificanceSTAT3 (signal transducer and activator of transcription 3) is a master transcription factor that organizes cellular responses to cytokines and growth factors and is implicated in inflammatory disorders. STAT3 is a well-recognized therapeutic target for human cancer and inflammatory disorders, but how its function is regulated in a cell type-specific manner has been a major outstanding question. We discovered that Stat3 imposes self-directed regulation through controlling transcription of its own regulator homeodomain-interacting protein kinase 2 ( Hipk2 ) in a T helper 17 (Th17) cell-specific manner. Our validation of the functional importance of the Stat3-Hipk2 axis in Th17 cell development in the pathogenesis of T cell-induced colitis in mice suggests an approach to therapeutically treat inflammatory bowel diseases that currently lack a safe and effective therapy.
Keyphrases
- transcription factor
- cell proliferation
- protein kinase
- dna binding
- single cell
- cell therapy
- endothelial cells
- gene expression
- genome wide identification
- squamous cell carcinoma
- regulatory t cells
- dendritic cells
- stem cells
- mesenchymal stem cells
- skeletal muscle
- immune response
- young adults
- induced pluripotent stem cells
- inflammatory response